Potential Silver Bullet for Swine Flu and Most Common Infections Using Green Technology Patented in U.S. ...( FORT LAUDERDALE Fla. June 24 /- Argen...),Health

FORT LAUDERDALE, Fla., June 24 /PRNewswire/ -- Argentech, Inc. (www.argentechinc.com) today announced that it reached agreement with Invision International Health Solutions, Inc., to purchase the rights to Opti-Silver, a patented antibacterial and antiviral technology that utilizes ionic silver in a unique complex for optimal delivery in the human body. The complex was granted broad patent protection in the U.S. and, recently, in Mexico as well. It also has patent protection overseas. (See www.silver100.com/patents.)

Recently, there has been a surge in the number of industrial and medically related products utilizing ionic silver, owing to its broad-spectrum antibacterial and antiviral qualities. University studies and regulatory approvals further attest to the antimicrobial powers of ionic silver, which is harmless to humans with normal use.

The mechanism of action by which ionic silver kills germs gives it this remarkable combination of characteristics. However, it's extremely unstable and requires a delivery mechanism to function.

The result of more than a million dollars in development, Opti-Silver was designed explicitly to optimize the delivery of silver ions in the human body.

"The Opti-Silver complex represents a quantum leap in utilizing ionic silver for internal human use," said Roger Leblanc, Ph.D., former director of the Departments of Chemistry and Advanced Microscopy at the University of Miami. "Nothing else even comes close to the efficiency of its unique delivery mechanism."

Donald Baird, Ph.D., former director of the Department of Chemistry at Florida Atlantic University, has called Opti-Silver "ingenious" and "unprecedented." (See www.silver100.com
'/>"/>